Home » Uncategorized » Glenmark bullish on drug discovery pipeline, eyes partnerships
Glenmark bullish on drug discovery pipeline, eyes partnerships

Glenmark bullish on drug discovery pipeline, eyes partnerships

Glenmark bullish on drug discovery pipeline, eyes partnerships

HYDERABAD: As many as six out of seven molecules in Glenmark’s drug discovery pipeline are currently in the clinical trial stage and the company’s R&D spend pegged at 10 per cent of sales is expected to be maintained at similar levels for next two years, a top official has said.

Pain, inflammation and oncology are the therapeutic areas currently the drug maker is working on, said Glenn Saldanha, Chairman & Managing Director, Glenmark PharmaceuticalsBSE 0.40 % Ltd.

“C ..

Thanks for the comment

BIGTheme.net • Free Website Templates - Downlaod Full Themes
Social Media Auto Publish Powered By : XYZScripts.com